These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Martin KR; Quigley HA; Zack DJ; Levkovitch-Verbin H; Kielczewski J; Valenta D; Baumrind L; Pease ME; Klein RL; Hauswirth WW Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4357-65. PubMed ID: 14507880 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060 [TBL] [Abstract][Full Text] [Related]
4. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Pease ME; Zack DJ; Berlinicke C; Bloom K; Cone F; Wang Y; Klein RL; Hauswirth WW; Quigley HA Invest Ophthalmol Vis Sci; 2009 May; 50(5):2194-200. PubMed ID: 19060281 [TBL] [Abstract][Full Text] [Related]
5. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Zhou Y; Pernet V; Hauswirth WW; Di Polo A Mol Ther; 2005 Sep; 12(3):402-12. PubMed ID: 15975850 [TBL] [Abstract][Full Text] [Related]
6. Comparison between axonal and retinal ganglion cell gene expression in various optic nerve injuries including glaucoma. Levkovitch-Verbin H; Makarovsky D; Vander S Mol Vis; 2013; 19():2526-41. PubMed ID: 24357921 [TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus-mediated expression of growth-associated protein-43 aggravates retinal ganglion cell death in experimental chronic glaucomatous injury. Huang C; Cen LP; Liu L; Leaver SG; Harvey AR; Cui Q; Pang CP; Zhang M Mol Vis; 2013; 19():1422-32. PubMed ID: 23825922 [TBL] [Abstract][Full Text] [Related]
8. AAV-mediated transfer of RhoA shRNA and CNTF promotes retinal ganglion cell survival and axon regeneration. Cen LP; Liang JJ; Chen JH; Harvey AR; Ng TK; Zhang M; Pang CP; Cui Q; Fan YM Neuroscience; 2017 Feb; 343():472-482. PubMed ID: 28017835 [TBL] [Abstract][Full Text] [Related]
9. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574 [TBL] [Abstract][Full Text] [Related]
10. Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure. Yue J; Khan RS; Duong TT; Dine KE; Cui QN; O'Neill N; Aravand P; Liu T; Chaqour B; Shindler KS; Ross AG Neurotherapeutics; 2023 Apr; 20(3):896-907. PubMed ID: 36941497 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Hains BC; Waxman SG Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Phatak NR; Stankowska DL; Krishnamoorthy RR Mol Vis; 2016; 22():1048-61. PubMed ID: 27587945 [TBL] [Abstract][Full Text] [Related]
13. Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells. Langouet-Astrie CJ; Yang Z; Polisetti SM; Welsbie DS; Hauswirth WW; Zack DJ; Merbs SL; Enke RA Exp Eye Res; 2016 Oct; 151():61-7. PubMed ID: 27481653 [TBL] [Abstract][Full Text] [Related]
14. Soluble Nogo-66 receptor prevents synaptic dysfunction and rescues retinal ganglion cell loss in chronic glaucoma. Fu QL; Liao XX; Li X; Chen D; Shi J; Wen W; Lee DH; So KF Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8374-80. PubMed ID: 21948553 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131 [TBL] [Abstract][Full Text] [Related]
16. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Leaver SG; Cui Q; Plant GW; Arulpragasam A; Hisheh S; Verhaagen J; Harvey AR Gene Ther; 2006 Sep; 13(18):1328-41. PubMed ID: 16708079 [TBL] [Abstract][Full Text] [Related]
17. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy. Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782 [TBL] [Abstract][Full Text] [Related]
18. Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma. Bond WS; Hines-Beard J; GoldenMerry YL; Davis M; Farooque A; Sappington RM; Calkins DJ; Rex TS Mol Ther; 2016 Feb; 24(2):230-239. PubMed ID: 26502777 [TBL] [Abstract][Full Text] [Related]
19. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. McKinnon SJ; Lehman DM; Kerrigan-Baumrind LA; Merges CA; Pease ME; Kerrigan DF; Ransom NL; Tahzib NG; Reitsamer HA; Levkovitch-Verbin H; Quigley HA; Zack DJ Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1077-87. PubMed ID: 11923249 [TBL] [Abstract][Full Text] [Related]
20. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]